PPAR-γ signaling crosstalk in mesenchymal stem cells

PPAR Research

Volumn , Issue , 2010, Pages

  Takada, Ichiro ^a   Kouzmenko, Alexander P ^b   Kato, Shigeaki ^c  

^a KEIO UNIVERSITY   (Japan)

^b ALFAISAL UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE METHYLTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN; WNT5A PROTEIN;

ADIPOCYTE; ADIPOGENESIS; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DNA RESPONSIVE ELEMENT; MESENCHYMAL STEM CELL; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; TRANSACTIVATION;

EID: 77956797254     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/341671     Document Type: Review

References (41)

1. Michalik L., Auwerx J., Berger J. P., Chatterjee V. K., Glass C. K., Gonzalez F. J., Grimaldi P. A., Kadowaki T., Lazar M. A., O'Rahilly S., Palmer C. N. A., Plutzky J., Reddy J. K., Spiegelman B. M., Staels B., Wahli W., International union of pharmacology. LXI. Peroxisome proliferator-activated receptors Pharmacological Reviews 2006 58 4 726 741
2. Nolte R. T., Wisely G. B., Westin S., Cobb J. E., Lambert M. H., Kurokawa R., Rosenfeld M. G., Willson T. M., Glass C. K., Milburn M. V., Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor- Nature 1998 395 6698 137 143
3. Rosenfeld M. G., Lunyak V. V., Glass C. K., Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response Genes and Development 2006 20 11 1405 1428
4. Kouzarides T., Chromatin modifications and their function Cell 2007 128 4 693 705
5. Allis C. D., Berger S. L., Cote J., Dent S., Jenuwien T., Kouzarides T., Pillus L., Reinberg D., Shi Y., Shiekhattar R., Shilatifard A., Workman J., Zhang Y., New nomenclature for chromatin-modifying enzymes Cell 2007 131 4 633 636
6. Fujiki R., Chikanishi T., Hashiba W., Ito H., Takada I., Roeder R. G., Kitagawa H., Kato S., GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis Nature 2009 459 7245 455 459
7. Huang N., vom Baur E., Garnier J.-M., Lerouge T., Vonesch J.-L., Lutz Y., Chambon P., Losson R., Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators EMBO Journal 1998 17 12 3398 3412
8. Garcia-Bassets I., Kwon Y.-S., Telese F., Prefontaine G. G., Hutt K. R., Cheng C. S., Ju B.-G., Ohgi K. A., Wang J., Escoubet-Lozach L., Rose D., Glass C. K., Fu X.-D., Rosenfeld M. G., Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors Cell 2007 128 3 505 518
9. Kitagawa H., Fujiki R., Yoshimura K., Mezaki Y., Uematsu Y., Matsui D., Ogawa S., Unno K., Okubo M., Tokita A., Nakagawa T., Ito T., Ishimi Y., Nagasawa H., Matsumoto T., Yanagisawa J., Kato S., The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome Cell 2003 113 7 905 917
10. Lemon B., Inouye C., King D. S., Tjian R., Selectivity of chromatin-remodelling cofactors for ligand-activated transcription Nature 2001 414 6866 924 928
11. Bao Y., Shen X., SnapShot: chromatin remodeling complexes Cell 2007 129 3 632
12. Kishimoto M., Fujiki R., Takezawa S., Sasaki Y., Nakamura T., Yamaoka K., Kitagawa H., Kato S., Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications Endocrine Journal 2006 53 2 157 172
13. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P., Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase Science 1995 270 5241 1491 1494
14. Suzawa M., Takada I., Yanagisawa J., Ohtake F., Ogawa S., Yamauchi T., Kadowaki T., Takeuchi Y., Shibuya H., Gotoh Y., Matsumoto K., Kato S., Cytokines suppress adipogenesis and PPAR- function through the TAK1/TAB1/NIK cascade Nature Cell Biology 2003 5 3 224 230
15. Hu E., Kim J. B., Sarraf P., Spiegelman B. M., Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR Science 1996 274 5295 2100 2103
16. Pascual G., Fong A. L., Ogawa S., Gamliel A., Li A. C., Perissi V., Rose D. W., Willson T. M., Rosenfeld M. G., Glass C. K., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR- Nature 2005 437 7059 759 763
17. Shao D., Rangwala S. M., Bailey S. T., Krakow S. L., Reginato M. J., Lazar M. A., Interdomain communication regulating ligand binding by PPAR- Nature 1998 396 6709 377 380
18. van Beekum O., Fleskens V., Kalkhoven E., Posttranslational modifications of PPAR- : fine-tuning the metabolic master regulator Obesity 2009 17 2 213 219
19. Takada I., Kouzmenko A. P., Kato S., Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis Nature Reviews. Rheumatology 2009 5 8 442 447
20. Arthur A., Zannettino A., Gronthos S., The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair Journal of Cellular Physiology 2009 218 2 237 245
21. Hamada H., Kobune M., Nakamura K., Kawano Y., Kato K., Honmou O., Houkin K., Matsunaga T., Niitsu Y., Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy Cancer Science 2005 96 3 149 156
22. Muruganandan S., Roman A. A., Sinal C. J., Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program Cellular and Molecular Life Sciences 2009 66 2 236 253
23. Hong J.-H., Hwang E. S., McManus M. T., Amsterdam A., Tian Y., Kalmukova R., Mueller E., Benjamin T., Spiegelman B. M., Sharp P. A., Hopkins N., Yaffe M. B., TAZ, a transcriptional modulator of mesenchymal stem cell differentiation Science 2005 309 5737 1074 1078
24. Spinella-Jaegle S., Rawadi G., Kawai S., Gallea S., Faucheu C., Mollat P., Courtois B., Bergaud B., Ramez V., Blanchet A. M., Adelmant G., Baron R., Roman-Roman S., Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation Journal of Cell Science 2001 114 11 2085 2094
25. Baumann C. A., Ribon V., Kanzaki M., Thurmond D. C., Mora S., Shigematsu S., Bickel P. E., Pessin J. E., Saltiel A. R., CAP defines a second signalling pathway required for insulin-stimulated glucose transport Nature 2000 407 6801 202 207
26. Ribon V., Johnson J. H., Camp H. S., Saltiel A. R., Thiazolidinediones and insulin resistance: peroxisome proliferator-activated receptor activation stimulates expression of the CAP gene Proceedings of the National Academy of Sciences of the United States of America 1998 95 25 14751 14756
27. Ricote M., Li A. C., Willson T. M., Kelly C. J., Glass C. K., The peroxisome proliferator-activated receptor- is a negative regulator of macrophage activation Nature 1998 391 6662 79 82
28. Takada I., Mihara M., Suzawa M., Ohtake F., Kobayashi S., Igarashi M., Youn M.-Y., Takeyama K.-I., Nakamura T., Mezaki Y., Takezawa S., Yogiashi Y., Kitagawa H., Yamada G., Takada S., Minami Y., Shibuya H., Matsumoto K., Kato S., A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR- transactivation Nature Cell Biology 2007 9 11 1273 1285
29. Kortenjann M., Nehls M., Smith A. J. H., Carsetti R., Schler J., Khler G., Boehm T., Abnormal bone marrow stroma in mice deficient for nemo-like kinase, Nlk European Journal of Immunology 2001 31 12 3580 3587
30. Yanagisawa J., Kitagawa H., Yanagida M., Wada O., Ogawa S., Nakagomi M., Oishi H., Yamamoto Y., Nagasawa H., McMahon S. B., Cole M. D., Tora L., Takahashi N., Kato S., Nuclear receptor function requires a TFTC-type histone acetyl transferase complex Molecular Cell 2002 9 3 553 562
31. Vissers L. E. L. M., van Ravenswaaij C. M. A., Admiraal R., Hurst J. A., de Vries B. B. A., Janssen I. M., Van Der Vliet W. A., Huys E. H. L. P. G., De Jong P. J., Hamel B. C. J., Schoenmakers E. F. P. M., Brunner H. G., Veltman J. A., Van Kessel A. G., Mutations in a new member of the chromodomain gene family cause CHARGE syndrome Nature Genetics 2004 36 9 955 957
32. Wang H., An W., Cao R., Xia L., Erdjument-Bromage H., Chatton B., Tempst P., Roeder R. G., Zhang Y., mAM facilitates conversion by ESET of dimethyl to trimethyl lysine 9 of histone H3 to cause transcriptional repression Molecular Cell 2003 12 2 475 487
33. Schultz D. C., Ayyanathan K., Negorev D., Maul G. G., Rauscher F. J. III, SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins Genes and Development 2002 16 8 919 932
34. Tontonoz P., Hu E., Graves R. A., Budavari A. I., Spiegelman B. M., mPPAR 2: tissue-specific regulator of an adipocyte enhancer Genes and Development 1994 8 10 1224 1234
35. Kurahashi T., Nomura T., Kanei-Ishii C., Shinkai Y., Ishii S., The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3 Molecular Biology of the Cell 2005 16 10 4705 4713
36. Glass D. A. II, Bialek P., Ahn J. D., Starbuck M., Patel M. S., Clevers H., Taketo M. M., Long F., McMahon A. P., Lang R. A., Karsenty G., Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation Developmental Cell 2005 8 5 751 764
37. Gong Y., Slee R. B., Fukai N., Rawadi G., Roman-Roman S., Reginato A. M., Wang H., Cundy T., Glorieux F. H., Lev D., Zacharin M., Oexle K., Marcelino J., Suwairi W., Heeger S., Sabatakos G., Apte S., Adkins W. N., Allgrove J., Arslan-Kirchner M., Batch J. A., Beighton P., Black G. C. M., Boles R. G., Boon L. M., Borrone C., Brunner H. G., Carle G. F., Dallapiccola B., De Paepe A., Floege B., Halfhide M. L., Hall B., Hennekam R. C., Hirose T., Jans A., Jppner H., Kim C. A., Keppler-Noreuil K., Kohlschuetter A., LaCombe D., Lambert M., Lemyre E., Letteboer T., Peltonen L., Ramesar R. S., Romanengo M., Somer H., Steichen-Gersdorf E., Steinmann B., Sullivan B., Superti-Furga A., Swoboda W., Van den Boogaard M.-J., Van Hul W., Vikkula M., Votruba M., Zabel B., Garcia T., Baron R., Olsen B. R., Warman M. L., LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development Cell 2001 107 4 513 523
38. Ross S. E., Hemati N., Longo K. A., Bennett C. N., Lucas P. C., Erickson R. L., MacDougald O. A., Inhibition of adipogenesis by Wnt signaling Science 2000 289 5481 950 953
39. Takada I., Kouzmenko A. P., Kato S., Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies Expert Opinion on Therapeutic Targets 2009 13 5 593 603
40. Wan Y., Chong L.-W., Evans R. M., PPAR- regulates osteoclastogenesis in mice Nature Medicine 2007 13 12 1496 1503
41. Guan Y., Hao C., Cha D. R., Rao R., Lu W., Kohan D. E., Magnuson M. A., Redha R., Zhang Y., Breyer M. D., Thiazolidinediones expand body fluid volume through PPAR stimulation of ENaC-mediated renal salt absorption Nature Medicine 2005 11 8 861 866